# Ono Pharmaceutical Co., Ltd. (OPHLF)

> Source: Nexqual · https://nexqual.com/OPHLF · data as of 2026-10-21 20:00 UTC · cite as "Nexqual, Ono Pharmaceutical Co., Ltd. (OPHLF), nexqual.com/OPHLF" · informational, not investment advice.

**Price:** USD 15.3 (+0.92% on the day) · last close of Oct 21, 2026; US market closed, not a live price. Prev close 15.16 · day 15.3–15.3 · 52w 11.08–18.67 · market cap $7.19B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y +30.7% vs S&P 500 +14.4%; 5Y +26.7% vs S&P 500 +77.0%.
- Next earnings: 2026-10-29, EPS estimate USD —, revenue estimate $117B.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2024-08-12) |
|---|---|---|
| Total return | +30.7% | +26.7% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | +30.9% | +11.4% |
| Volatility (annualized) | 45.7% | 51.6% |
| Max drawdown | -27.0% (Feb 2026→Jul 2026) | -39.4% (Sep 2024→Jan 2025) |

## Peers (Drug Manufacturers - General)
GRFS (Grifols, S.A.) USD 7.54 +1.14% · OGN (Organon & Co.) USD 13.76 +0.07% · BIIB (Biogen Inc.) USD 250.37 -1.37% · SNY (Sanofi) USD 41.5 -1.11% · GSK (GSK plc) USD 50.63 -1.13% · BMY (Bristol-Myers Squibb Company) USD 61.56 -2.29%

## More
Full page: https://nexqual.com/OPHLF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $116.61B | — |
| Next quarter (ends 2026-12-31) | — | — | — | $122.00B | — |
| Current fiscal year (ends 2027-03-31) | — | — | — | $460.91B | — |
| Next fiscal year (ends 2028-03-31) | — | — | — | $448.89B | — |